Data / Form D filings / SPR Therapeutics, Inc.
SPR Therapeutics, Inc.: Form D filings
SPR Therapeutics, Inc., a health care company in Cleveland, OH, filed 13 Form D notices with the SEC between 2011 and 2024. The latest, on February 5, 2024, reports $25.6 million sold of a $25.6 million offering to 39 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 22901 MILLCREEK BOULEVARD, SUITE 500, Cleveland, OH, 44122
- Phone
- (216) 378-9108
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1532647
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | New notice | $25,641,473 | $25,641,473 | 39 | Jan 30, 2024 | sec.gov | |
| Aug 31, 2021 | New notice | $35,000,000 | $20,000,000 | $15,000,000 | 1 | Aug 20, 2021 | sec.gov |
| Jan 30, 2019 | New notice | $20,000,000 | $8,000,000 | $12,000,000 | 1 | Jan 18, 2019 | sec.gov |
| Sep 21, 2017 | New notice | $18,834,388 | $15,000,000 | $3,834,388 | 1 | Sep 8, 2017 | sec.gov |
| Jul 24, 2017 | Amendment | $4,000,000 | $1,111,895 | $2,888,105 | 12 | Apr 30, 2017 | sec.gov |
| May 5, 2017 | New notice | $3,000,000 | $581,895 | $2,418,105 | 6 | Apr 30, 2017 | sec.gov |
| Oct 7, 2016 | Amendment | $6,000,000 | $5,725,881 | $274,119 | 57 | Jul 14, 2015 | sec.gov |
| Feb 2, 2016 | Amendment | $5,000,000 | $1,925,411 | $3,074,589 | 23 | Jul 14, 2015 | sec.gov |
| Jul 21, 2015 | New notice | $3,000,000 | $519,249 | $2,480,751 | 0 | Jul 14, 2015 | sec.gov |
| Jun 9, 2014 | Amendment | $4,300,000 | $3,931,699 | $368,301 | 28 | Nov 1, 2013 | sec.gov |
| Oct 31, 2013 | New notice | $3,750,000 | $0 | $3,750,000 | 0 | Yet to occur | sec.gov |
| Jan 13, 2012 | Amendment | $2,500,000 | $2,202,566 | $297,434 | 17 | Oct 1, 2011 | sec.gov |
| Oct 14, 2011 | New notice | $2,000,000 | $999,936 | $1,000,064 | 6 | Oct 1, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Josh J. Boggs | Executive Officer | |
| Michael J. Chuisano | Director | |
| Geoffrey B. Thrope | Director | |
| Ben J. Austin | Executive Officer | |
| Maria E. Bennett | Executive Officer, Director | |
| Nicholas J. Valeriani | Director | |
| Robert B. Blankenship | Director |
Other health care companies in Ohio that filed recently
- SymKardia, Inc. $4.3 million · Oct 28, 2026
- GHCI HEALTHCARE FUND HOLDINGS, L.P. $50,000 · Oct 28, 2026
- Skelo Wear, LLC $500,000 · Oct 9, 2026
- Creo Health, LLC $500,000 · Sep 10, 2026
- Steribite, LLC $711,758 · Sep 2, 2026
- UGen Health Inc. $2.4 million · Aug 26, 2026
Every Form D from the week of Feb 5, 2024 · All recent filings in Ohio · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what SPR Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.